Effects of rosiglitazone on postprandial leukocytes and cytokines in type 2 diabetes
- 31 May 2006
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 186 (1) , 152-159
- https://doi.org/10.1016/j.atherosclerosis.2005.07.001
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosisJournal of the American College of Cardiology, 2004
- Inflammation and atherosclerosis: role of C-Reactive protein in risk assessmentThe American Journal of Medicine, 2004
- Neutrophil Infiltration of Culprit Lesions in Acute Coronary SyndromesCirculation, 2002
- Correlations between peripheral differential leukocyte counts and carotid atherosclerosis in non-smokersAtherosclerosis, 2001
- AtherosclerosisNature, 2000
- Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort studyThe Lancet, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine, 1998
- Leukocyte Count and Risk of Major Coronary Heart Disease EventsAmerican Journal of Epidemiology, 1992
- The Leukocyte Count as a Predictor of Myocardial InfarctionNew England Journal of Medicine, 1974